Filing Details
- Accession Number:
- 0001209191-17-041449
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-22 18:12:08
- Reporting Period:
- 2017-06-20
- Filing Date:
- 2017-06-22
- Accepted Time:
- 2017-06-22 18:12:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1423824 | Alder Biopharmaceuticals Inc | ALDR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604800 | L T Jeffrey Smith | 11804 North Creek Parkway South Bothell WA 98011 | Sr. Vp Translational Medicine | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-20 | 585 | $0.99 | 1,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-20 | 585 | $20.00 | 831 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-20 | 585 | $0.00 | 585 | $0.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,324 | 2019-04-20 | No | 4 | M | Direct |
Footnotes
- The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2017.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2017.
- The shares subject to this stock option are fully vested.
Billionaire Hedge Funds
